National Institute Of Cardiovascular Diseases, Pakistan
Clinical trials sponsored by National Institute Of Cardiovascular Diseases, Pakistan, explained in plain language.
-
Heart drug may prevent 'No-Reflow' after stenting
Disease control Recruiting nowThis study tests whether giving the drug adenosine before emergency angioplasty (stenting) can prevent the 'no-reflow' problem, where blood still doesn't flow well after the artery is opened. About 1,148 adults having a heart attack (STEMI) will be randomly assigned to receive ad…
Phase: PHASE4 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Balloon vs stent: could a simple balloon be better for young heart attack survivors?
Disease control Recruiting nowThis study compares two treatments for young adults (ages 18-50) having a severe heart attack called STEMI. One group gets a drug-coated balloon that expands and then is removed, leaving nothing behind. The other gets a permanent drug-eluting stent. The goal is to see if the ball…
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
10,000 volunteers needed to Fine-Tune heart disease prediction
Knowledge-focused Recruiting nowThis study aims to improve how doctors assess and manage heart disease risk in 10,000 adults. Researchers will use standard risk scores to categorize participants and track outcomes. The goal is to find the best ways to prevent heart attacks and deaths.
Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC